PRO99 MULTI-CRITERIA DECISION ANALYSIS (MCDA) OF ELTROMBOPAG OLAMINE IN THE TREATMENT OF PATIENTS WITH REFRACTORY SEVERE APLASTIC ANEMIA UNDER THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL: A HEALTH TECHNOLOGY ASSESSMENT (HTA) ALTERNATIVE MODEL

Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.2429
https://www.valueinhealthjournal.com/article/S1098-3015(19)34807-7/fulltext
Section Title :
Section Order : 12124
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34807-7&doi=10.1016/j.jval.2019.09.2429
HEOR Topics :
Tags :
Regions :